We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$1.36B
Cap. Flow
+$773M
Cap. Flow %
6.06%
Top 10 Hldgs %
12.57%
Holding
2,812
New
294
Increased
855
Reduced
703
Closed
290

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$28.3M
2
HAL icon
Halliburton
HAL
+$24.2M
3
EA icon
Electronic Arts
EA
+$23.9M
4
ICON
Iconix Brand Group, Inc.
ICON
+$23.7M
5
HELE icon
Helen of Troy
HELE
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 14.92%
2 Healthcare 14.07%
3 Industrials 12.64%
4 Financials 10.64%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ET icon
351
Energy Transfer Partners
ET
$70.1B
$8.79M 0.07%
306,592
-6,190
-2% -$178K
DGX icon
352
Quest Diagnostics
DGX
$25.1B
$8.55M 0.07%
127,578
+7,021
+6% +$443K
GLD icon
353
SPDR Gold Trust
GLD
$131B
$8.52M 0.07%
74,988
-2,018
-3% -$233K
LNC icon
354
Lincoln National
LNC
$7.91B
$8.46M 0.07%
146,775
-18,088
-11% -$984K
ADI icon
355
Analog Devices
ADI
$181B
$8.44M 0.07%
152,062
+6,373
+4% +$325K
OKE icon
356
Oneok
OKE
$58.7B
$8.43M 0.07%
169,243
+120,484
+247% +$6.65M
PSA icon
357
Public Storage
PSA
$60.2B
$8.35M 0.07%
45,150
+1,193
+3% +$216K
EFV icon
358
iShares MSCI EAFE Value ETF
EFV
$27.6B
$8.31M 0.07%
162,845
+10,400
+7% +$549K
KLAC icon
359
KLA
KLAC
$275B
$8.3M 0.07%
1,180,980
-3,310
-0.3% -$24.4K
RNR icon
360
RenaissanceRe
RNR
$13.7B
$8.3M 0.07%
85,348
+56
+0.1% +$5.57K
IWV icon
361
iShares Russell 3000 ETF
IWV
$19.5B
$8.27M 0.06%
67,638
+677
+1% +$80.8K
ROK icon
362
Rockwell Automation
ROK
$51.4B
$8.09M 0.06%
72,767
+53,600
+280% +$5.88M
IWD icon
363
iShares Russell 1000 Value ETF
IWD
$82B
$7.98M 0.06%
76,490
+17,536
+30% +$1.79M
DVN icon
364
Devon Energy
DVN
$51.9B
$7.88M 0.06%
128,837
+1,833
+1% +$111K
GSK icon
365
GSK
GSK
$103B
$7.86M 0.06%
147,061
+17,107
+13% +$957K
RSG icon
366
Republic Services
RSG
$66.7B
$7.83M 0.06%
194,575
+189,390
+3,653% +$7.42M
SHW icon
367
Sherwin-Williams
SHW
$78.3B
$7.83M 0.06%
89,283
-5,373
-6% -$423K
FCX icon
368
Freeport-McMoran
FCX
$90B
$7.79M 0.06%
333,669
-50,434
-13% -$1.39M
NOC icon
369
Northrop Grumman
NOC
$77B
$7.66M 0.06%
51,974
-81,531
-61% -$11.2M
CLX icon
370
Clorox
CLX
$11.6B
$7.64M 0.06%
73,322
-1,024
-1% -$102K
HP icon
371
Helmerich & Payne
HP
$3.53B
$7.6M 0.06%
112,767
-61,498
-35% -$4.79M
OCR
372
DELISTED
OMNICARE INC
OCR
$7.55M 0.06%
103,488
+2,048
+2% +$139K
RGP
373
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$7.52M 0.06%
313,285
-11,141
-3% -$315K
SEIC icon
374
SEI Investments
SEIC
$11.9B
$7.5M 0.06%
187,450
+125,995
+205% +$4.83M
CDK
375
DELISTED
CDK Global, Inc.
CDK
$7.39M 0.06%
+181,485
New +$6.43M

Similar funds

Glenmede Trust's Q4 2014 Portfolio in Review

As of Q4 2014, Glenmede Trust held 2,812 positions worth $12.8B, up 12% from $11.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust deployed $773M of net new capital in Q4 2014, opening 294 new positions and adding to 855 existing holdings. Its largest new stake was Portland General Electric: 447,386 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was eBay, an estimated $18.8M trimmed.

  • Glenmede Trust's largest Q4 2014 buy was Portland General Electric: 447,386 shares worth $16.9M.
  • Glenmede Trust added most to Labcorp in Q4 2014, an estimated $28.3M increase.
  • Glenmede Trust's biggest Q4 2014 reduction was eBay, cutting an estimated $18.8M.
  • Glenmede Trust fully exited SAPIENT CORP in Q4 2014, selling an estimated $16.9M.
  • Glenmede Trust's ten largest holdings make up 13% of its $12.8B portfolio in Q4 2014.
  • Glenmede Trust opened 294 new positions and closed 290 in Q4 2014.
  • Glenmede Trust's portfolio value rose 12% quarter-over-quarter to $12.8B.

Based on Glenmede Trust's 13F filing for Q4 2014, filed 6 Feb 2015.